Low bone mineral density and fractures in stages 3–5 CKD: an updated systematic review and meta-analysis

[1]  Tatjana Kehler,et al.  [Epidemiology of osteoporosis and osteoporotic fractures]. , 2014, Reumatizam.

[2]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[3]  Á. Gil,et al.  Are healthcare workers’ intentions to vaccinate related to their knowledge, beliefs and attitudes? a systematic review , 2013, BMC Public Health.

[4]  S. Jamal,et al.  Bone mineral density by DXA and HR pQCT can discriminate fracture status in men and women with stages 3 to 5 chronic kidney disease , 2012, Osteoporosis International.

[5]  S. Sasaki,et al.  Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients--a single-center cohort study. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  C. Krestan,et al.  Bone microarchitecture in hemodialysis patients assessed by HR-pQCT. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[7]  S. Cremers,et al.  Discriminants of prevalent fractures in chronic kidney disease. , 2011, Journal of the American Society of Nephrology : JASN.

[8]  S. Cummings,et al.  Effects of denosumab on fracture and bone mineral density by level of kidney function , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  K. Abernethy.  Webwise: The online fracture risk assessment (FRAX) tool was developed by the World Health Organization , 2011 .

[10]  David A Hanley,et al.  2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary , 2010, Canadian Medical Association Journal.

[11]  E. Shane,et al.  Bone mass and microarchitecture in CKD patients with fracture. , 2010, Journal of the American Society of Nephrology : JASN.

[12]  K. Berta,et al.  Vitamin D insufficiency and bone fractures in patients on maintenance hemodialysis , 2010, International Urology and Nephrology.

[13]  Claire Bombardier,et al.  2009 Updated Method Guidelines for Systematic Reviews in the Cochrane Back Review Group , 2009, Spine.

[14]  A. Macleod,et al.  Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease- Mineral and Bone Disorder (CKD-MBD) , 2009 .

[15]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.

[16]  Supplemental Tables,et al.  KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). , 2009, Kidney international. Supplement.

[17]  S. Cummings,et al.  The effect of raloxifene treatment in postmenopausal women with CKD. , 2008, Journal of the American Society of Nephrology : JASN.

[18]  J. Beyene,et al.  Low bone mineral density and fractures in long-term hemodialysis patients: a meta-analysis. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[19]  S. Cummings,et al.  Alendronate Treatment in Women With Normal to Severely Impaired Renal Function: An Analysis of the Fracture Intervention Trial , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  S. Cummings,et al.  Renal function and risk of hip and vertebral fractures in older women. , 2007, Archives of internal medicine.

[21]  D. Bauer,et al.  Cortical PQCT Measures Are Associated With Fractures in Dialysis Patients , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[22]  E. Schwartz,et al.  Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment , 2006, Osteoporosis International.

[23]  S. Boonen,et al.  Safety and Efficacy of Risedronate in Patients With Age‐Related Reduced Renal Function as Estimated by the Cockcroft and Gault Method: A Pooled Analysis of Nine Clinical Trials , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  M. Inaba,et al.  Increased Incidence of Vertebral Fracture in Older Female Hemodialyzed Patients with Type 2 Diabetes Mellitus , 2005, Calcified Tissue International.

[25]  C. Baudoin,et al.  Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[26]  K. Chihara,et al.  Risk Factors for Hip Fracture in Hemodialysis Patients , 2002, American Journal of Nephrology.

[27]  G. Hawker,et al.  Bone density and heel ultrasound testing do not identify patients with dialysis-dependent renal failure who have had fractures. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[28]  Jacques P. Brown,et al.  2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. , 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[29]  M. A. Fontaine,et al.  Fracture and bone mineral density in hemodialysis patients. , 2000, Clinical nephrology.

[30]  Craig S. Wong,et al.  Increased risk of hip fracture among patients with end-stage renal disease. , 2000, Kidney international.

[31]  E. Seeman,et al.  Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone. , 1999, The Journal of clinical endocrinology and metabolism.

[32]  A. Parfitt.  A Structural Approach to Renal Bone Disease , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[33]  Jesse A Berlin,et al.  Does blinding of readers affect the results of meta-analyses? , 1997, The Lancet.

[34]  J. Tsubota,et al.  Retrospective study on the usefulness of radius and lumbar bone density in the separation of hemodialysis patients with fractures from those without fractures. , 1996, Bone.

[35]  S. Cummings,et al.  Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. , 1995, The New England journal of medicine.

[36]  S. Cummings,et al.  Bone mass measurements and risk of fracture in Caucasian women: a review of findings from prospective studies. , 1995, The American journal of medicine.

[37]  Harry K. Genant,et al.  Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. , 1993, The American journal of medicine.

[38]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[39]  J L Kelsey,et al.  Epidemiology of osteoporosis and osteoporotic fractures. , 1985, Epidemiologic reviews.